The patent covers compounds that inhibit V-ATPase and their use in the manufacture of medicaments for treating viral ...
The relationship between dermatology and aesthetic medicine is one of the most compelling issues in recent years. Dermatology ...
The company will use the capital to develop its R&D and technology capabilities, proprietary processes, scale-up capabilities ...
Dr Villoo Morawala Patell, founder of Avesthagen and Avestagenome Project International, discusses how India can turn its ...
As production becomes more complex and highly regulated, digitalisation and automation are emerging as critical enablers. G ...
Zydus Lifesciences (Zydus) and Formycon AG (Formycon) have announced that the US Food and Drug Administration (USFDA) has accepted for review the Biologics License Application (BLA) for FYB206, a ...
The US remains a key market for Indian pharma. But changing conditions are pushing India to diversify its global footprint.
The VIGOR programme will advance four drug candidates from TRL-4 to TRL-6 over three years, covering preclinical development ...
Cohance Lifesciences, a technology-driven, integrated contract development and manufacturing organisation (CDMO), has ...
Akums Drugs & Pharma Ltd., a contract development and manufacturing organisation (CDMO), has introduced a portfolio of ...
Granules India Limited (GIL) announced that it has submitted a Paragraph IV certification in connection with its ANDA for ...
Zydus Lifesciences (Zydus), in partnership with MSN Laboratories (MSN), has announced the launch of Riociguat Tablets, 0.5 mg ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results